Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
06/2003
06/18/2003EP1318840A2 PHOSPHATONIN-RELATED GENE AND i METHODS OF USE THEREOF /i
06/18/2003EP1318839A2 Methods of treating neoplasia with combinations of target cell-specific adenovirus, chemotherapy and radiation
06/18/2003EP1318837A2 Method of treating estrogen receptor positive carcinoma
06/18/2003EP1318836A2 Treatment of hyperproliferative diseases
06/18/2003EP1318834A2 Compositions comprising mixtures of human cytokines and methods of producing the same
06/18/2003EP1318830A2 Notch receptor agonists and uses
06/18/2003EP1318817A1 Use of arginine in the preparation of a medicament for the prevention and treatment of the side effects associated with the intravenous administration of pharmaceuticals
06/18/2003EP1318814A2 Triazole compounds useful as protein kinase inhibitors
06/18/2003EP1318807A1 Photosensitizing ointment
06/18/2003EP1318796A2 Polynucleotide intercalator interceptors and inhibitors
06/18/2003EP1318794A2 Method for reducing toxicity of combined chemotherapies
06/18/2003EP1275377B1 Granulates containing liposoluble substances and process of preparation thereof
06/18/2003EP1232247A4 Modulation of signal transduction
06/18/2003EP1171578B1 Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof
06/18/2003EP1171128B1 Combination of n-butyldeoxynojirimycin (nb-dnj) and glycolipid degrading enzymes in therapy
06/18/2003EP1151005B1 Peptide variants of the tumour marker muc1 and the use thereof
06/18/2003EP1135401B1 Glyceryl nucleotides, method for the production thereof and their use
06/18/2003EP1115704B1 Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes
06/18/2003EP1064291B1 Methods of synthesizing gm3
06/18/2003EP0981338B1 Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp. infection
06/18/2003EP0920623B1 Boron neutron capture therapy using pre-targeting methods
06/18/2003EP0821739B1 An adenovirus helper-virus system
06/18/2003CN1425073A 病毒株 Strains
06/18/2003CN1425066A Novel stra6 polypeptides
06/18/2003CN1425065A Method of controlling telomere length
06/18/2003CN1425062A Dioxygenases catalyzing asymetric cleavage of beta-carotene
06/18/2003CN1425015A Chlorophyll and bacteriochlorophyll esters, and their preparation
06/18/2003CN1425010A Cyclic compound
06/18/2003CN1425009A Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
06/18/2003CN1425004A N-substituted metal proteinase inhibitor with heterocyclic side chain
06/18/2003CN1424918A Remedies for diseases in association with decreasing in bone mass
06/18/2003CN1424913A Antivirus medicine
06/18/2003CN1424912A Composition comprising camptothecin and pyrimidine derivative for the treatment of cancer
06/18/2003CN1424870A Nuclear transfer with selected donor cells
06/18/2003CN1424401A Conditional duplicated adenovirus and its establishment and use
06/18/2003CN1424312A Specific indole compound and its preparation and use in treating and preventing cancers
06/18/2003CN1424111A Hyacinth bletilla micro-balls for liver and kidney arterial embolism
06/18/2003CN1424071A Auxiliary medicine for treating esophagus cancer and processing method thereof
06/18/2003CN1424067A Medicines for treating cancers and tumours
06/18/2003CN1424062A Chinese medicine for gastrointestinal cancers and its preparation
06/18/2003CN1424058A Pure Chinese medicine preparation for treating liver cancer
06/18/2003CN1424057A Chinese medicine immune regulator and its preparation and use in pharmacy
06/18/2003CN1424051A Lyophilized scorpion venoms powder injection
06/18/2003CN1424032A Capsule agent with grape-seed extracts as raw material
06/18/2003CN1424028A Medicine for treating cancers and use thereof
06/18/2003CN1111531C Process for preparing 6-0-monoesters of castanospermine
06/18/2003CN1111520C Matrix metalloprotease inhibitors
06/18/2003CN1111414C Use of magnesium salts or magnesium complex as production of medicines
06/18/2003CN1111409C Use of cytosine in preparation of medicines for treatment of cancers
06/18/2003CN1111357C Food products having enhanced cocoa polyphenol content and processes for producing same
06/17/2003US6579983 5-cyano-2-aminopyrimidine derivatives
06/17/2003US6579982 Treating inflammation, cancer
06/17/2003US6579973 Compositions for the treatment and diagnosis of breast cancer and methods for their use
06/17/2003US6579970 Specific octapeptides, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds and immune effector cells raised in response to presentation of these epitopes.
06/17/2003US6579969 Purified polypeptide of given amino acid sequence; serine/threonine kinase
06/17/2003US6579967 Cyclic peptide of given amino acid sequence; improves binding strength by adding a carbamoyl moiety at N-terminus; useful in determining tissue/cellular expression and in drug screening
06/17/2003US6579903 Klainetins and their derivatives, method for their preparation and use thereof
06/17/2003US6579893 Related thiazolidinediones
06/17/2003US6579891 Metal ion chelating agent such as picolinic acid or derivatives; zinc finger protein in a canine lymphoma cell
06/17/2003US6579890 Matrix metalloprotease inhibitors
06/17/2003US6579887 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents
06/17/2003US6579877 Combination of benzoquinazoline antifolates and protecting agents
06/17/2003US6579874 Substituted azoles
06/17/2003US6579869 Cephalotaxanes: their method of preparation and their use in treatment of cancers, leukemias, parasites, including those resistant to usual chemotherapeutic agents, and as reversal agents
06/17/2003US6579861 Administering alpha -hydroxy-2-methylene-19-nor-homopregnacalciferol for therapy of psoriasis
06/17/2003US6579856 Inhibition of stress activated protein kinase (SAPK) pathway and sensitization of cells to cancer therapies
06/17/2003US6579855 Adenovirus-mediated gene therapy
06/17/2003US6579709 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
06/17/2003US6579691 DNA sequence encoding a neuronal protein kinase (NPK) which phosphorylates tau proteins as well as other microtubule associated proteins (MAPs) in positions crucial for the binding to microtubules, alzheimers disease, antitumor
06/17/2003US6579683 A ligand which is a member of Ephrin family of Eph family receptor interactive protein has been shown to be expressed by arterial endothelial cells but not by venous endothelial cell, useful for distinguishing target artieris and veins
06/17/2003US6579525 Pharmaceutical compositions comprising erythropoietin for treatment of cancer
06/17/2003US6579522 Replication deficient adenoviral TNF vector
06/17/2003CA2279099C New 8h-thieno-[2,3-b]pyrrolizine-8-one derivatives, their preparation process, and pharmaceutical compositions containing these derivatives
06/17/2003CA2118816C Composition for introducing nucleic acid complexes into higher eucaryotic cells
06/17/2003CA2046654C Radiolabeled proteins for diagnostic or therapeutic use
06/13/2003WO2003047602A1 Immunostimulatory oligodeoxynucleotides
06/13/2003CA2452909A1 Immunostimulatory oligodeoxynucleotides
06/12/2003WO2003048729A2 Discovery of therapeutic products
06/12/2003WO2003048379A1 T-bet compositions and methods of use thereof
06/12/2003WO2003048360A1 NOVEL PROTEINS BINDING TO MAMMALIAN TARGET OF RAPAMYCIN (mTOR) AND GENES THEREOF
06/12/2003WO2003048352A2 Histone h3 methyltransferase polypeptide
06/12/2003WO2003048337A2 Antibody to latent membrane proteins and uses thereof
06/12/2003WO2003048334A2 Immunocytokines with modulated selectivity
06/12/2003WO2003048328A2 Antibodies against carboxic anhydrase ix (ca ix) tumor antigen
06/12/2003WO2003048306A2 Polycistronic expression of antibodies
06/12/2003WO2003048209A1 Bispecific anti-cd19 x anti-cd16 antibodies and uses thereof
06/12/2003WO2003048207A2 Anti-dota antibody
06/12/2003WO2003048205A2 Novel proteins with il-6 inhibiting activity
06/12/2003WO2003048200A1 Nuclear protein 'shoca' - a component of the wnt signalling pathway
06/12/2003WO2003048199A1 Cytotoxic protein and utilization thereof
06/12/2003WO2003048193A2 GIPs, A FAMILY OF POLYPEPTIDES WITH TRANSCRIPTION FACTOR ACTIVITY THAT INTERACT WITH GOODPASTURE ANTIGEN BINDING PROTEIN
06/12/2003WO2003048168A2 Trioxane derivatives as antimalaria or anticancer compounds
06/12/2003WO2003048167A1 Trioxane derivatives
06/12/2003WO2003048166A1 Podophyllotoxins as antiproliferative agents
06/12/2003WO2003048162A1 Novel crystalline compound
06/12/2003WO2003048159A1 Quinoline derivatives
06/12/2003WO2003048141A1 Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof
06/12/2003WO2003048133A1 Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i)
06/12/2003WO2003048129A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same
06/12/2003WO2003048127A1 Aromatic heterocyclic non-covalent inhibitors of urokinase and blood vessel formation
1 ... 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 ... 2211